Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
Clinical trial NCT06212960 · COMPLETED
Trial details
- NCT number
- NCT06212960
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-28
- Primary completion
- 2024-02-26
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.